SANOFI INDIA NEWS
Stocks in news: Tata Motors, Avenue Supermarts, Welspun Enterprises, Infosys
Indian stock markets finished higher on Friday. Financial stocks and foreign investor inflows boosted the Sensex and Nifty. Tata Consultancy Services' weaker earnings limited broader gains. Several companies like Avenue Supermarts, Tata Motors, and Infosys will be in focus. Tata Motors' stock will trade as a consolidated entity for the last time on Monday.
US stocks futures move as Dow, S&P 500, Nasdaq fluctuate on Trump’s tariffs and PCE inflation data
US stock futures moved up and down as traders watched new tariff news and waited for an inflation report. Some big companies like Intel, Eli Lilly, and Paccar saw stock moves before markets opened. Investors are careful because of tariff plans, government worries, and global market reactions. Oil prices also showed gains this week.
Stocks in news: Axis Bank, Tech Mahindra, Wipro, LTIMindtree, Angel One
Markets remained range-bound due to lack of fresh catalysts, with several companies in focus for Q1 results. Tech Mahindra reported a significant profit increase, while Angel One's profit declined. Reliance Power approved a substantial fundraising plan, and Godrej Properties expanded its land holdings in Raipur.
Mankind may end up spinning out a winner in consumer brands unit
The company entered the OTC business in 2007 and it has grown to have established brands such as Manforce, HealthOK, Prega News, AcneStar, Unwanted and Gas-O-Fast. Four of its brands ranked No.1 in their respective categories.
Sanofi India decides to put headquarters in Mumbai on the block
Sanofi's Indian subsidiary is planning to sell its 150,000 sq ft standalone property in Mumbai's Powai area, which serves as its current headquarters, to focus on monetization and operational consolidation. The move follows the acquisition of a long-term lease for an office in Vikhroli suburb, where Sanofi Consumer Healthcare will relocate as part of a broader strategy. The Powai property sale is expected to yield approximately Rs 250 crore based on current market rates.
Add Sanofi India, target price Rs 9170: ICICI Securities
Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 19074.08 Crore) operating in Pharmaceuticals sector.
- Go To Page 1
Stocks in news: Angel One, CDSL, Apollo Pipes, Cipla, Aster DM Healthcare
Equity indices declined on Tuesday. Angel One, CDSL, Apollo Pipes, Cipla, Aster DM Healthcare among top stocks to track today.
Hold Sanofi India, target price Rs 9170: ICICI Securities
Sanofi India Ltd. key Products/Revenue Segments include Pharmaceutical Products, Sale of services, Other Operating Revenue, Export Incentives and Scrap for the year ending 31-Dec-2022.
Stocks in news: LIC, Hero MotoCorp, Nykaa, Adani Wilmar, Biocon
Hero MotoCorp reported a 32% growth in net profit for the quarter ended June to Rs 825 crore. Revenue from operations grew 4.5% YoY to Rs 8,767 crore.
Buy Sanofi India, target price Rs 6738: ICICI Securities
Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 12894.50 Crore) operating in Pharmaceuticals sector.
Hold Sanofi India, target price Rs 6885: ICICI Direct
Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 13611.10 Crore) operating in Pharmaceuticals sector.
Buy Sanofi India, target price Rs 8500: Centrum Broking
Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 14647.01 Crore) operating in Pharmaceuticals sector.
Bayer's consumer health unit plans to step up India play
In an interview to ET, Sandeep Verma, country head, India, Bayer consumer health division in India, said the company will use its global expertise to launch new formats such as effervescent tablets, topicals and sprays and expand its distribution footprint from 5.5 lakh pharmacies to 10 lakh by 2026, besides launching marketing campaigns to energize the brands.
Add Sanofi India, target price Rs 7955: ICICI Securities
Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 16181.43 Crore) operating in Pharmaceuticals sector.
Add Sanofi India, target price Rs 8107: ICICI Securities
Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 16790.24 Crore) operating in Pharmaceuticals sector.
Add Sanofi India, target price Rs 8107: ICICI Securities
Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 16767.21 Crore) operating in Pharmaceuticals sector.
Sanofi India skids 2% on poor earnings scorecard
Sanofi India’s counter fell to a low of Rs 7,159 as against the previous close of Rs 7,280.40 on the National Stock Exchange.
Sanofi India's managing director Rajaram Narayanan steps down
"In these roles, he has led the strategic reorientation of the organisation, sharpening its focus on core areas, developing new business models, building future talent and driving digital transformation across all areas of the business," the company said.
Buy Sanofi India, target price Rs 9750: ICICI Direct
Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 18856.90 Crore) operating in Pharmaceuticals sector.
Add Sanofi India, target price Rs 8633: ICICI Securities
Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 18666.32 Crore) operating in Pharmaceuticals sector.
Buy Sanofi India, target price Rs 9820: ICICI Direct
Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 18756.37 Crore) operating in Pharmaceuticals sector.
Add Sanofi India, target price Rs 8594: ICICI Securities
Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 18632.00 Crore) operating in Pharmaceuticals sector.
Hold Sanofi India, target price Rs 8731: ICICI Securities
Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 19158.83 Crore) operating in Pharmaceuticals sector.
Trending stocks: Sanofi India shares up over 1%
A total of 330 shares changed hands on the counter till 10:50AM (IST).
IDFC Securities maintains outperformer on Sanofi India, target price Rs 7,368
Outperform Sanofi India Ltd. at a price target of Rs 7368.0 .
Aventis Pharma seals deal to buy Universal Medicare
The deal is expected to close in the fourth quarter of 2011, according to a statement issued by Aventis Pharma.
Glenmark inks $325-mn licensing deal with Sanofi
Glenmark Pharmaceuticals licensed its chronic pain molecule to Sanofi Aventis for an upfront payment of $20 million (approximately Rs 89 crore), in a cumulative deal of $325 million (Rs 1,449 crore), the companies said on Monday.
Piramal Health up 13% on Sanofi stake buy
The news of French drug major Sanofi-Aventis picking up stake in Piramal Healthcare at a premium has resulted in its stock price trading at Rs 202, about 13% higher from the previous close on BSE at 10:50 am.
Load More
